Bristol Myers Squibb
Search results
Learn how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing treatments. Explore the therapies for Hematology, Oncology, Inflammation and Immunology and the medical research to help people live longer, better, and healthier.
Celgene is a Bristol-Myers Squibb company. Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb.
About Celgene I&I Author: test Created Date: 7/17/2015 12:03:28 PM ...
To report SUSPECTED ADVERSE REACTIONS contact Celgene Corporation at 1-888-423-5436 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. -----DRUG INTERACTIONS----- Digoxin: Periodic monitoring of digoxin plasma levels is recommended due to increased Cmax and AUC with concomitant REVLIMID therapy
Since Celgene PAC was established in 2012, Celgene has issued reports twice a year, during the quarter following the end of each half of the year, including all contributions made by Celgene PAC and Celgene Corporation to candidates and political committees at both the federal and state level.
Mar 22, 2018 · PART III: CONSUMER INFORMATION Pr VIDAZA® azacitidine for injection • This leaflet is part III of a three-part "Product Monograph" published when VIDAZA® was approved for sale in Canada and is designed specifically for
Celgene is a Bristol-Myers Squibb company. Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb.
Celgene Inc.* 2344 Alfred-Nobel Blvd Suite 300 Saint-Laurent, QC H4S 0A4 Date of Revision: March 26, 2021 . Page 2 of 43 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION.....3 SUMMARY PRODUCT INFORMATION ...
Otexla Safety Data Sheet. Otezla-15Jul2019-Ver2.3.01 ...
